Susan Collins actually said...

"As Senator Murray indicated, it is ironic that we have addressed and modernized the FDA in so many other areas but not in this one."

"Our bill is the product of consultations with a wide range of stakeholders, as Senator Feinstein has mentioned, and it would give the FDA broader oversight."

"I think it underscores why we need a national standard, because if you're going to be selling across State lines, it is just not feasible to have 50 different approaches to this issue."

"Essentially what Mylan is doing, as you confirmed, is just changing the label on its product and then selling it for a lower price."